RUBY
Rubius Therapeutics, Inc
RUBY
RUBY
Delisted
RUBY was delisted on the 6th of March, 2023.
42 hedge funds and large institutions have $11.2M invested in Rubius Therapeutics, Inc in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 15 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
79% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 24
Holders
42
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$168K | |
| 2 | +$19.6K | |
| 3 | +$16.6K | |
| 4 |
E
Ergoteles
New York
|
+$15.8K |
| 5 |
VF
Virtu Financial
New York
|
+$11.3K |
Top Sellers
| 1 | -$295K | |
| 2 | -$236K | |
| 3 | -$196K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$184K |
| 5 |
AVM
Arch Venture Management
Chicago,
Illinois
|
-$152K |